Literature DB >> 29409226

Surgical management of large talar osteochondral defects using autologous chondrocyte implantation.

Brandon Erickson1, Yale Fillingham1, Michael Hellman1, Selene G Parekh2, Christopher E Gross3.   

Abstract

BACKGROUND: Talar osteochondral lesions (OLT) occur frequently in ankle sprains and fractures. We hypothesize that matrix-induced autologous chondrocyte implantation (MACI) will have a low reoperation rate and high patient satisfaction rate in treating OLT less than 2.5cm2.
METHODS: A systematic review was registered with PROSPERO and performed with PRISMA guidelines using three publicly available free databases. Clinical outcome investigations reporting OLT outcomes with levels of evidence I-IV were eligible for inclusion. All study, subject, and surgical technique demographics were analyzed and compared. Statistics were calculated using Student's t-tests, one-way ANOVA, chi-squared, and two-proportion Z-tests.
RESULTS: Nineteen articles met our inclusion criteria, which resulted in a total of 343 patients. Six studies pertained to arthroscopic MACI, 8 to open MACI, and 5 studies to open periosteal ACI (PACI). All studies were Level IV evidence. Due to study quality, imprecise and sparse data, and potential for reporting bias, the quality of evidence is low. In comparison of open and arthroscopic MACI, we found both advantages favoring open MACI. However, open MACI had higher complication rates.
CONCLUSIONS: No procedure demonstrates superiority or inferiority between the combination of open or arthroscopic MACI and PACI in the management of OLT less than 2.5cm2. Ultimately, well-designed randomized trials are needed to address the limitation of the available literature and further our understanding of the optimal treatment options.
Copyright © 2017 European Foot and Ankle Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autologous chondrocyte implantation; Osteochondral lesion; Talus

Mesh:

Year:  2017        PMID: 29409226     DOI: 10.1016/j.fas.2017.01.002

Source DB:  PubMed          Journal:  Foot Ankle Surg        ISSN: 1268-7731            Impact factor:   2.705


  6 in total

1.  Influence of the Medial Malleolus Osteotomy on the Clinical Outcome of M-BMS + I/III Collagen Scaffold in Medial Talar Osteochondral Lesion (German Cartilage Register/Knorpelregister DGOU).

Authors:  Oliver Gottschalk; Sebastian Felix Baumbach; Sebastian Altenberger; Daniel Körner; Matthias Aurich; Christian Plaass; Sarah Ettinger; Daniel Guenther; Christoph Becher; Hubert Hörterer; Markus Walther
Journal:  Cartilage       Date:  2020-10-08       Impact factor: 3.117

2.  Efficacy and safety of autologous chondrocyte implantation for osteochondral defects of the talus: a systematic review and meta-analysis.

Authors:  Mu Hu; Xingchen Li; Xiangyang Xu
Journal:  Arch Orthop Trauma Surg       Date:  2021-06-14       Impact factor: 3.067

3.  High-Density Autologous Chondrocyte Implantation as Treatment for Ankle Osteochondral Defects.

Authors:  Juan Manuel López-Alcorocho; Isabel Guillén-Vicente; Elena Rodríguez-Iñigo; Ramón Navarro; Rosa Caballero-Santos; Marta Guillén-Vicente; Mercedes Casqueiro; Tomás F Fernández-Jaén; Fernando Sanz; Santiago Arauz; Steve Abelow; Pedro Guillén-García
Journal:  Cartilage       Date:  2019-03-17       Impact factor: 4.634

Review 4.  Osteochondritis Dissecans: Current Understanding of Epidemiology, Etiology, Management, and Outcomes.

Authors:  Michael M Chau; Mikhail A Klimstra; Kelsey L Wise; Jutta M Ellermann; Ferenc Tóth; Cathy S Carlson; Bradley J Nelson; Marc A Tompkins
Journal:  J Bone Joint Surg Am       Date:  2021-06-16       Impact factor: 6.558

Review 5.  Osteochondral Lesions of the Talus: A Review on Talus Osteochondral Injuries, Including Osteochondritis Dissecans.

Authors:  Juergen Bruns; Christian Habermann; Mathias Werner
Journal:  Cartilage       Date:  2021-01-09       Impact factor: 3.117

6.  [Research progress in surgical procedures for osteochondral lesions of talus].

Authors:  Xinbo Wu; Haichao Zhou; Yunfeng Yang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2019-10-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.